Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.810
+0.010 (0.56%)
At close: Sep 18, 2025, 4:00 PM EDT
1.888
+0.078 (4.32%)
After-hours: Sep 18, 2025, 7:14 PM EDT
Immuron Market Cap
Immuron has a market cap or net worth of $13.31 million as of September 18, 2025. Its market cap has decreased by -12.44% in one year.
Market Cap
13.31M
Enterprise Value
11.51M
1-Year Change
-12.44%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $13.31M, a decrease of -52.63%. That is a compound annual growth rate of -8.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 10.50M | 8.25% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.98B |
| Johnson & Johnson | 423.17B |
| AbbVie | 389.99B |
| UnitedHealth Group | 311.15B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 231.85B |